Insulet Corporation

Insulet's Q2 2026 Earnings: What to Expect

Insulet will release its second-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Yahoo Finance · 22/07/2026 · lire l'article ↗

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

ACTON, Mass., July 14, 2026--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced a global partnership with Calm, a leading consumer mental health company, to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals. The partnership launches Calm’s first-ever integrated content partnership and collection with a MedTech co

Yahoo Finance · 14/07/2026 · lire l'article ↗

Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Blood Glucose Monitoring System Market size & share revenue was valued at approximately USD 16.8 Billion in 2025 and is expected to reach USD 18.3 Billion in 2026 and is expected to reach around USD 39.4 Billion by 2035, at a CAGR of 8.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Insulet Corporati

Yahoo Finance · 14/07/2026 · lire l'article ↗

Insulet Corporation (PODD) Fell Along with Broad Medtech Sector

ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “SMID Cap Growth Strategy”. A copy can be downloaded here. Small and mid-cap (SMID) growth equities experienced the strongest quarter in recent memory, with the Russell 2500 Growth Index rising 24.0%, driven by enthusiasm for AI infrastructure and higher-beta momentum stocks. The […]

Yahoo Finance · 13/07/2026 · lire l'article ↗

Here's How Much You'd Have If You Invested $1000 in Insulet a Decade Ago

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Yahoo Finance · 13/07/2026 · lire l'article ↗

Insulet (PODD) Stock Still Trades At A Premium As Shares Fell 47%

Insulet stock has fallen sharply over the past year, yet the valuation checks still lean toward the shares being on the expensive side rather than a clear bargain. Insulet is down 46.8% over the past year, which means anyone looking at the stock today is doing so after a significant reset in the share price. On the one hand, growth expectations around the Omnipod franchise may support the current price. On the other hand, class action lawsuits and an FDA Class I recall highlight product and...

Yahoo Finance · 10/07/2026 · lire l'article ↗